Gadolinium-based contrast agents (GBCAs) have revolutionized MRI, enabling physicians
to obtain crucial life-saving medical information that often cannot be obtained with other …

In the past 4 years, many publications described a concentration-dependent deposition of
gadolinium in the brain both in adults and children, seen as high signal intensities in the …

Ever since gadolinium was found to deposit in the brain of patients with normal kidney
function by Kanda et al. in 2014, several studies have been conducted to evaluate its effect …

Purpose To validate accuracy of diagnosis of developmental dysplasia of the hip (DDH) from
geometric properties of acetabular shape extracted from three-dimensional (3D) …

After the initial report in 2014 on T1-weighted (T1w) hyperintensity of deep brain nuclei
following serial injections of linear gadolinium-based contrast agents (GBCAs), a multitude …

Background Accumulation of macrocyclic gadolinium agents in children's brains remain to
be determined. Purpose To demonstrate whether there is an intracranial macrocyclic …

Background Increased cerebral signal intensity (SI) has been reported in patients
undergoing MRI with gadolinium-based contrast agents (GBCAs). Published data on …

Objective: To evaluate the distribution and characteristics of peripheral nerve abnormalities
in chronic inflammatory demyelinating polyneuropathy (CIDP) using magnetic resonance …

Objectives The aim of this study was to determine the following in patients who have
undergone magnetic resonance imaging with gadolinium-based contrast agents (GBCAs) …

Objectives Gadolinium deposition is widely believed to occur, but questions regarding
accumulation pattern and permanence remain. We conducted a retrospective study of …